Shigehiro Katayama

12.0k total citations · 1 hit paper
224 papers, 8.2k citations indexed

About

Shigehiro Katayama is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shigehiro Katayama has authored 224 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Endocrinology, Diabetes and Metabolism, 59 papers in Molecular Biology and 42 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shigehiro Katayama's work include Blood Pressure and Hypertension Studies (27 papers), Diabetes Treatment and Management (23 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers). Shigehiro Katayama is often cited by papers focused on Blood Pressure and Hypertension Studies (27 papers), Diabetes Treatment and Management (23 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers). Shigehiro Katayama collaborates with scholars based in Japan, United States and Netherlands. Shigehiro Katayama's co-authors include Takuya Awata, Ikuo Inoue, Kouichi Inukai, Susumu Kurihara, Tsugikazu Komoda, Masaki Watanabe, Sadayoshi Ito, Tomoko Ohkubo, Toshisuke Morita and Shigeru Hokari and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Shigehiro Katayama

223 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

2011 522 citations Hermann Haller, Sadayoshi Ito et al. profile →

Peers

Countries citing papers authored by Shigehiro Katayama

Since Specialization

Citations

This map shows the geographic impact of Shigehiro Katayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigehiro Katayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigehiro Katayama more than expected).

Fields of papers citing papers by Shigehiro Katayama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigehiro Katayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigehiro Katayama. The network helps show where Shigehiro Katayama may publish in the future.

Co-authorship network of co-authors of Shigehiro Katayama

This figure shows the co-authorship network connecting the top 25 collaborators of Shigehiro Katayama. A scholar is included among the top collaborators of Shigehiro Katayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigehiro Katayama. Shigehiro Katayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A randomized controlled study of finerenone versus placebo in Japanese patients with type 2 diabetes mellitus and diabetic nephropathy 2016 ·Journal of Diabetes and its Complications ·Shigehiro Katayama, Daishiro Yamada, Mikihiro Nakayama, Takashi Yamada, Masafumi Myoishi, Masaharu Kato, Christina Nowack, Peter Kolkhof, Yoshimitsu Yamasaki	105
2	Cerebral antioxidant enzyme increase associated with learning deficit in type 2 diabetes rats 2012 ·Brain Research ·(unknown), Tomokazu Shimazu, Hajime Hasegawa, Ikuo Inoue, Hidemasa Hayashibe, Hironori Nagasaka, Nobuo Araki, Shigehiro Katayama, Masahiko Nomura, Shuichi Watanabe	16
3	Prevention of microalbuminuria in type 2 diabetes (ROADMAP Trial) 2010 ·Diabetologia ·Hermann Haller, Seiki Ito, Joseph L. Izzo, Andrzej Januszewicz, Shigehiro Katayama, Jan Menne, A Mimran, Ton J. Rabelink, Eberhard Ritz, Luís M. Ruilope, L. C. Rump, Giancarlo Viberti	3
4	Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study 2009 ·Diabetologia ·Eberhard Ritz, G. C. Viberti, Luís M. Ruilope, Ton J. Rabelink, (unknown), Shigehiro Katayama, Sadayoshi Ito, A Mimran, Jan Menne, L. C. Rump, Andrzej Januszewicz, Hermann Haller	36
5	Rapid and Simple Profiling of Lipoproteins by Polyacrylamide-Gel Disc Electrophoresis to Determine the Heterogeneity of Low-Density Lipoproteins (LDLs) Including Small, Dense LDL 2009 ·Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) ·Takanari Nakano, Ikuo Inoue, Makoto Seo, Seiichiro Takahashi, Takuya Awata, Tsugikazu Komoda, Shigehiro Katayama	12
6	LKB1, an upstream AMPK kinase, regulates glucose and lipid metabolism in cultured liver and muscle cells 2006 ·Biochemical and Biophysical Research Communications ·Kenta Imai, Kouichi Inukai, (unknown), Takuya Awata, Shigehiro Katayama	46
7	Definition and diagnostic criteria of metabolic syndrome. 2005 ·Yūji Matsuzawa, Yasuo Ikeda, Shigehiro Katayama, (unknown), (unknown), (unknown), (unknown), Hiroshi Makino, Toshiro Fujita	65
8	[Prevalence and incidence of diabetic microangiopathy in Japan]. 2005 ·PubMed ·Hirohito Sone, Nobuhiro Yamada, Hidetoshi Yamashita, Shigehiro Katayama, Yasuo Akanuma	1
9	CLOCK/BMAL1 is Involved in Lipid Metabolism via Transactivation of the Peroxisome Proliferator-activated Receptor (PPAR) Response Element 2005 ·Journal of Atherosclerosis and Thrombosis ·Ikuo Inoue, Yuichi Shinoda, Masaaki Ikeda, Kenji Hayashi, (unknown), Masahiko Nomura, (unknown), (unknown), Shinichiro Kawai, Takuya Awata, Tsugikazu Komoda, Shigehiro Katayama	112
10	Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes 2005 ·Biochemical and Biophysical Research Communications ·Takuya Awata, Susumu Kurihara, Nobuki Takata, (unknown), Hiroyuki Iizuka, Tomoko Ohkubo, (unknown), Masaki Watanabe, Youhei Nakashima, Kouichi Inukai, Ikuo Inoue, Izumi Kawasaki, Keisuke Mori, Shin Yoneya, Shigehiro Katayama	114
11	Erectile Dysfunction in Hypertensive Rats Results from Impairment of the Relaxation Evoked by Neurogenic Carbon Monoxide and Nitric Oxide 2004 ·Hypertension Research ·(unknown), Toshisuke Morita, (unknown), Shinji Yagi, Shigehiro Katayama	70
12	Pro12Ala substitution in peroxisome proliferator-activated receptorγ2 is associated with low adiponectin concentrations in young Japanese men 2004 ·Metabolism ·Nobuki Takata, Takuya Awata, Kouichi Inukai, Masaki Watanabe, Tomoko Ohkubo, Susumu Kurihara, (unknown), Shigehiro Katayama	25
13	Glycated high-density lipoprotein regulates reactive oxygen species and reactive nitrogen species in endothelial cells 2003 ·Metabolism ·Toshiyuki Matsunaga, Takanori Nakajima, Takashi Miyazaki, Iwao Koyama, Shigeru Hokari, Ikuo Inoue, (unknown), (unknown), Shigehiro Katayama, Akira Hara, Tsugikazu Komoda	32
14	Carbon monoxide regulates blood pressure cooperatively with nitric oxide in hypertensive rats 2002 ·Heart and Vessels ·(unknown), Toshisuke Morita, Shigehiro Katayama	29
15	A case of primary mucoepidermoid carcinoma of the thyroid: molecular evidence of its origin 2002 ·Clinical Endocrinology ·Akinobu Minagawa, Makoto Iitaka, Miho Suzuki, S. Yasuda, Kaori Kameyama, Shio Shimada, Shinji Kitahama, Seiki Wada, Shigehiro Katayama	38
16	Missense Variations of the Gene Responsible for Wolfram Syndrome (WFS1/wolframin) in Japanese: Possible Contribution of the Arg456His Mutation to Type 1 Diabetes as a Nonautoimmune Genetic Basis 2000 ·Biochemical and Biophysical Research Communications ·Takuya Awata, (unknown), Susumu Kurihara, Tomoko Ohkubo, Ikuo Inoue, Takahiro Abe, Hirofumi Takino, Yasunori Kanazawa, Shigehiro Katayama	39
17	Effect of Dietary Oleic Acid on Metabolism of Lipid in the Rats. Studies with Tea Oil and Olive Oil. 1999 ·Nippon Eiyo Shokuryo Gakkaishi ·(unknown), Keiichi Takahashi, (unknown), Ikuo Inoue, (unknown), Shigehiro Katayama, (unknown)	1
18	Increased Serum Vascular Endothelial Growth Factor Levels and Intrathyroidal Vascular Area in Patients with Graves’ Disease and Hashimoto’s Thyroiditis 1998 ·The Journal of Clinical Endocrinology & Metabolism ·Makoto Iitaka, Shiro Miura, (unknown), (unknown), Shinji Kitahama, (unknown), (unknown), (unknown), Seiki Wada, Shigehiro Katayama	98
19	Bradykinin May Not Be Involved in Improvement of Insulin Resistance by Angiotensin Converting Enzyme Inhibitor 1996 ·Clinical and Experimental Hypertension ·Sufang Chen, (unknown), (unknown), Jun Ishii, Shigehiro Katayama	13
20	Plasma Levels of Atrial Natriuretic Hormone in Cushing’s Syndrome* 1988 ·The Journal of Clinical Endocrinology & Metabolism ·TOHRU YAMAJI, Miyuki Ishibashi, Akira Yamada, Fumimaro Takaku, Akira Itabashi, Shigehiro Katayama, Jun Ishii, (unknown), Takanori Fukushima	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact